These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 29746286)

  • 21. Effects of ranolazine on disease-specific health status and quality of life among patients with acute coronary syndromes: results from the MERLIN-TIMI 36 randomized trial.
    Arnold SV; Morrow DA; Wang K; Lei Y; Mahoney EM; Scirica BM; Braunwald E; Cohen DJ;
    Circ Cardiovasc Qual Outcomes; 2008 Nov; 1(2):107-15. PubMed ID: 20031797
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Ranolazine and Microvascular Angina by PET in the Emergency Department: Results From a Pilot Randomized Controlled Trial.
    Safdar B; D'Onofrio G; Dziura J; Russell RR; Johnson C; Sinusas AJ
    Clin Ther; 2017 Jan; 39(1):55-63. PubMed ID: 28081848
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Effect of Ranolazine in Patients with Chest Pain and Normal Coronaries- A Hospital Based Study.
    Saha S; Ete T; Kapoor M; Jha PK; Megeji RD; Kavi G; Warjri SB; Mishra A
    J Clin Diagn Res; 2017 Apr; 11(4):OC14-OC16. PubMed ID: 28571183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of ivabradine and ranolazine in patients with microvascular angina pectoris.
    Villano A; Di Franco A; Nerla R; Sestito A; Tarzia P; Lamendola P; Di Monaco A; Sarullo FM; Lanza GA; Crea F
    Am J Cardiol; 2013 Jul; 112(1):8-13. PubMed ID: 23558043
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of Ranolazine for Treatment of Coronary Microvascular Dysfunction-A Systematic Review and Meta-analysis of Randomized Trials.
    Kofler T; Hess S; Moccetti F; Pepine CJ; Attinger A; Wolfrum M; Toggweiler S; Kobza R; Cuculi F; Bossard M
    CJC Open; 2021 Jan; 3(1):101-108. PubMed ID: 33458636
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microvascular Assessment of Ranolazine in Non-Obstructive Atherosclerosis: The MARINA Randomized, Double-Blinded, Controlled Pilot Trial.
    Koh JS; Hung OY; Eshtehardi P; Kumar A; Rabah R; Raad M; Kumar S; Chaudhry S; Gupta S; Hosseini H; Brilakis E; Corban M; Sabbak N; Burnett GM; Liu C; Mehta PK; Quyyumi AA; Samady H
    Circ Cardiovasc Interv; 2020 Dec; 13(12):e008204. PubMed ID: 33272036
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Ranolazine in patients with incomplete revascularisation after percutaneous coronary intervention (RIVER-PCI): a multicentre, randomised, double-blind, placebo-controlled trial.
    Weisz G; Généreux P; Iñiguez A; Zurakowski A; Shechter M; Alexander KP; Dressler O; Osmukhina A; James S; Ohman EM; Ben-Yehuda O; Farzaneh-Far R; Stone GW;
    Lancet; 2016 Jan; 387(10014):136-45. PubMed ID: 26474810
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Relationship Between Optimism and Outcomes in Patients With Chronic Angina Pectoris.
    Fanaroff AC; Prather K; Brucker A; Wojdyla D; Davidson-Ray L; Mark DB; Williams RB; Barefoot J; Weisz G; Ben-Yehuda O; Stone GW; Ohman EM; Alexander KP
    Am J Cardiol; 2019 May; 123(9):1399-1405. PubMed ID: 30771861
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Should ranolazine be used for all patients with ischemic heart disease or only for symptomatic patients with stable angina or for those with refractory angina pectoris? A critical appraisal.
    Thadani U
    Expert Opin Pharmacother; 2012 Dec; 13(17):2555-63. PubMed ID: 23121448
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Update on evidence for treatment with ranolazine in stable angina.
    Carbone F; Montecucco F; Mach F
    Swiss Med Wkly; 2013; 143():w13874. PubMed ID: 24163124
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of Ranolazine on Ischemic Myocardium IN Patients With Acute Cardiac Ischemia (RIMINI-Trial): A Randomized Controlled Pilot Trial.
    Schwemer TF; Radziwolek L; Deutscher N; Diermann N; Sehner S; Blankenberg S; Friedrich FW
    J Cardiovasc Pharmacol Ther; 2019 Jan; 24(1):62-69. PubMed ID: 29938533
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effects of the Antianginal Drugs Ranolazine, Nicorandil, and Ivabradine on Coronary Microvascular Function in Patients With Nonobstructive Coronary Artery Disease: A Meta-analysis of Randomized Controlled Trials.
    Zhu H; Xu X; Fang X; Zheng J; Zhao Q; Chen T; Huang J
    Clin Ther; 2019 Oct; 41(10):2137-2152.e12. PubMed ID: 31548105
    [TBL] [Abstract][Full Text] [Related]  

  • 33. The use of ranolazine in non-anginal cardiovascular disorders: A review of current data and ongoing randomized clinical trials.
    Mihos CG; Krishna RK; Kherada N; Larrauri-Reyes M; Tolentino A; Santana O
    Pharmacol Res; 2016 Jan; 103():49-55. PubMed ID: 26546970
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Role of Ranolazine in cardiovascular disease and diabetes: Exploring beyond angina.
    Banerjee K; Ghosh RK; Kamatam S; Banerjee A; Gupta A
    Int J Cardiol; 2017 Jan; 227():556-564. PubMed ID: 27838121
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of ranolazine with atenolol, amlodipine, or diltiazem on exercise tolerance and angina frequency in patients with severe chronic angina: a randomized controlled trial.
    Chaitman BR; Pepine CJ; Parker JO; Skopal J; Chumakova G; Kuch J; Wang W; Skettino SL; Wolff AA;
    JAMA; 2004 Jan; 291(3):309-16. PubMed ID: 14734593
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Efficacy of Ranolazine in Patients With Symptomatic Hypertrophic Cardiomyopathy: The RESTYLE-HCM Randomized, Double-Blind, Placebo-Controlled Study.
    Olivotto I; Camici PG; Merlini PA; Rapezzi C; Patten M; Climent V; Sinagra G; Tomberli B; Marin F; Ehlermann P; Maier LS; Fornaro A; Jacobshagen C; Ganau A; Moretti L; Hernandez Madrid A; Coppini R; Reggiardo G; Poggesi C; Fattirolli F; Belardinelli L; Gensini G; Mugelli A
    Circ Heart Fail; 2018 Jan; 11(1):e004124. PubMed ID: 29321131
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Management of microvascular angina pectoris.
    Lanza GA; Parrinello R; Figliozzi S
    Am J Cardiovasc Drugs; 2014 Feb; 14(1):31-40. PubMed ID: 24174173
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Ranolazine: A Contemporary Review.
    Rayner-Hartley E; Sedlak T
    J Am Heart Assoc; 2016 Mar; 5(3):e003196. PubMed ID: 26979079
    [No Abstract]   [Full Text] [Related]  

  • 39. Ranolazine for improving coronary microvascular function in patients with nonobstructive coronary artery disease: a systematic review and meta-analysis with a trial sequential analysis of randomized controlled trials.
    Ling H; Fu S; Xu M; Wang B; Li B; Li Y; Liu X; Zhang X; Wang Q; Li A; Liu M
    Quant Imaging Med Surg; 2024 Feb; 14(2):1451-1465. PubMed ID: 38415135
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Long-Term (3 Years) Outcomes of Ranolazine Therapy for Refractory Angina Pectoris (from the Ranolazine Refractory Registry).
    Storey KM; Wang J; Garberich RF; Bennett NM; Traverse JH; Arndt TL; Schmidt CW; Henry TD
    Am J Cardiol; 2020 Aug; 129():1-4. PubMed ID: 32540170
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.